Calendario de inmunizaciones de la Asociación Española de Pediatría: recomendaciones 2023

Carrico, 2022, Value of the Immunization Program Children in the 2017 US Birth Cohort, Pediatrics., 150, 10.1542/peds.2021-056007 Centro Nacional de Epidemiología. CIBERESP. ISCIII. Informe epidemiológico sobre la situación de la tos ferina en España, 2005-2020. Madrid, Jul 2022 [consultado 30 Sep 2022]. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/archivos%20A-Z/TOSFERINA/Informe_Tosferina_2005-2020_Julio.2022.pdf Kandeil, 2020, A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis, Expert Rev Vaccines., 19, 621, 10.1080/14760584.2020.1791092 Gomme, 2022, The Impact of Timing of Pertussis Vaccination During Pregnancy on Infant Antibody Levels at Birth: A Multi-Country Analysis, Front Immunol., 13, 913922, 10.3389/fimmu.2022.913922 Perrett, 2020, Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large, randomized placebo-controlled trial, Vaccine., 38, 2105, 10.1016/j.vaccine.2019.10.104 Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Vigilancia epidemiológica de la hepatitis B en España, 2020. Madrid; junio 2022 [consultado 30 Sep 2022]. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/archivos%20A-Z/Hepatitis%20B/Vigilancia_HepatitisB_2020.pdf Savulescu, 2022, Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study, Vaccine., 40, 3963, 10.1016/j.vaccine.2022.05.011 Eichler, 2022, The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children, Eur J Clin Microbiol Infect Dis., 41, 439, 10.1007/s10096-021-04386-0 Marimon, 2021, Epidemiology of pneumococcal diseases in Spain after the introduction of pneumococcal conjugate vaccines, Enferm Infecc Microbiol Clin (Engl Ed)., 39, 142, 10.1016/j.eimc.2020.02.016 de Miguel, 2021, Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era, Clin Infect Dis., 73, e3778, 10.1093/cid/ciaa1483 Krishnarajah, 2014, Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States, Hum Vaccin Immunother., 10, 2255, 10.4161/hv.29511 Álvarez-Aldeán, 2019, Recomendaciones para la vacunación frente a ROTAvirus de los recién nacidos PREMaturos (ROTAPREM), An Pediatr (Barc)., 91, e1, 10.1016/j.anpedi.2019.06.001 Sun, 2021, Association of rotavirus vaccines with reduction in rotavirus gastroenteritis in children younger than 5 years: a systematic review and meta-analysis of randomized clinical trials and observational studies, JAMA Pediatr., 175, e210347, 10.1001/jamapediatrics.2021.0347 Ladhani, 2020, Vaccination of Infants with Meningococcal group B vaccine (4 CMenB) in England, N Engl J Med., 382, 309, 10.1056/NEJMoa1901229 Azzari, 2020, Effectiveness and impact of the 4 CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: a five-year retrospective observational study (2014-2018), Vaccines (Basel)., 8, 469, 10.3390/vaccines8030469 Rodrigues, 2020, Association of use of a meningococcus group B vaccine with group B invasive meningococcal disease among children in Portugal, JAMA., 324, 2187, 10.1001/jama.2020.20449 McMillan, 2021, Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis, Clin Infect Dis., 73, e609, 10.1093/cid/ciaa1733 Parikh, 2020, The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination, J Infect., 81, 483, 10.1016/j.jinf.2020.05.079 WHO: Vaccines against influenza. WHO position paper – November 2012 [consultado 30 Sep 2022]. Disponible en: https://apps.who.int/iris/handle/10665/241993 Centers for Disease Control and Prevention: 2019-20 Season's Pediatric Flu Deaths Tie High Mark Set During 2017-18 Season 2021 [consultado 30 Sep 2022]. Disponible en: https://www.cdc.gov/flu/spotlights/2019-2020/2019-20-pediatric-flu-deaths.htm Lacy, 2022, Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012-2018, Vaccine., 40, 444, 10.1016/j.vaccine.2021.12.011 Cilleruelo, 2019, Duration of immunity to measles, rubella and mumps during the first year of life, Vaccine., 37, 4164, 10.1016/j.vaccine.2019.05.056 Di Pietrantonj, 2020, Vaccines for measles, mumps, rubella, and varicella in children, Cochrane Database Syst Rev., 4, CD004407 Habib, 2021, Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants, Vaccine., 39, 3445, 10.1016/j.vaccine.2021.02.074 Widgren, 2022, Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?, Vaccine., 40, 673, 10.1016/j.vaccine.2021.11.063 FDA news release. Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age [consultado 30 Sep 2022]. Disponible en: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children CDC. Advisory Committee on Immunization Practices. COVID-19 ACIP Vaccine Recommendations [consultado 30 Sep 2022]. Disponible en: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html World Health Organization. Interim statement on COVID-19 vaccination for children. 11 August 2022 Statement [consultado 30 Sep 2022]. Disponible en: https://www.who.int/news/item/11-08-2022-interim-statement-on-covid-19-vaccination-for-children Ministerio de Sanidad. Gobierno de España. Estrategia de vacunación COVID-19 [consultado 30 Sep 2022]. Disponible en: https://www.vacunacovid.gob.es/ Dorabawila, 2022, Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant, medRxiv [Internet]. Sacco, 2022, Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, Lancet., 202, 97, 10.1016/S0140-6736(22)01185-0 Piché-Renaud, 2022, Vaccine Effectiveness of BNT162b2 Against Omicron in Children Aged 5-11 Years: A Test-Negative Design, Preprint The Lancet. Su JR. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. COVID-19 vaccine safety updates [consultado 30 Sep 2022]. Disponible en: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-01-05/02-covid-su-508.pdf Meites, 2019, Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices, MMWR Morb Mort Wkly Rep., 68, 698, 10.15585/mmwr.mm6832a3 Mix, 2021, Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study, Cancer Epidemiol Biomarkers Prev., 30, 30, 10.1158/1055-9965.EPI-20-0846 Katz, 2021, The impact of HPV vaccination on the prevalence of oropharyngeal cancer (OPC) in a hospital-based population: A cross-sectional study of patient's registry, J Oral Pathol Med., 50, 47, 10.1111/jop.13091 Egoavil, 2020, Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community-Spain (2008-2018), Vaccines (Basel)., 8, 117, 10.3390/vaccines8010117 Sánchez-Luna, 2016, Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004-2012, Curr Med Res Opin., 32, 693, 10.1185/03007995.2015.1136606 Hammitt, 2022, Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants, N Engl J Med., 386, 837, 10.1056/NEJMoa2110275 Griffin, 2020, Single Dose Nirsevimab for Prevention of RSV in Preterm Infants, N Engl J Med., 383, 415, 10.1056/NEJMoa1913556